The prevalence of human papilloma virus infection among women who admitted to Çukurova University Faculty of Medicine hospital;Çukurova Üniversitesi Tıp Fakültesi Hastanesine başvuran kadınlarda genital human papilomavirus enfeksiyon prevalans

Turkiye Klinikleri Journal of Medical Sciences

Volumn 31, Issue 2, 2011, Pages 307-314

  Altun, Zafer ^a   Yarkin, Fügen ^a   Vardar, Mehmet Ali ^a   Uǧuz, Aysun Hatice ^a  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Human papillomavirus 16; Human papillomavirus 18; Polymerase chain reaction; Prevalence; Uterine cervical neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 45; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; TURKEY (REPUBLIC); UNIVERSITY HOSPITAL; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS ISOLATION; WOMEN'S HEALTH;

EID: 80051719758     PISSN: 13000292     EISSN: None     Source Type: Journal    
DOI: 10.5336/medsci.2009-16463     Document Type: Article

References (34)

1. Yarkin F, Chauvin S, Konomi N, Wang W, Mo R, Bauchman G, et al. Detection of HPV DNA in cervical specimens collected in cytologic solution by ligation-dependent PCR. Acta Cytol 2003;47(3):450-6.
2. Yarki{dotless}n F, Vardar MA. [Immunology of HPV and natural infection]. Turkiye Klinikleri J Gynecol Obst-Special Topics 2009;2(1):43-7.
3. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 2006;110(5):525-41.
4. Petry KU, Menton S, Menton M, van Loenen-Frosch F, de Carvalho Gomes H, Holz B, et al. Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients. Br J Cancer 2003;88(10):1570-7.
5. Wright TC Jr, Schiffman M. Adding a test for human papillomavirus DNA to cervical-cancer screening. N Engl J Med 2003;348(6):489-90.
6. Medeiros R, Soares R, Vasconcelos A, Schmitt F, Lopes C. Glutathione S-transferase genotype GSTM1 as a predictor of elevated angiogenic phenotype in patients with early onset breast cancer. Angiogenesis 2004;7(1):53-8.
7. Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Desy M, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999;180(5):1415-23.
8. Siriaunkgul S, Suwiwat S, Settakorn J, Khunamornpong S, Tungsinmunkong K, Boonthum A, et al. HPV genotyping in cervical cancer in Northern Thailand: adapting the linear array HPV assay for use on paraffin-embedded tissue. Gynecol Oncol 2008;108(3):555-60.
9. Coutlee F, Voyer H. Effect of nonionic detergents on amplification of human papillomavirus DNA with consensus primers MY09 and MY11. J Clin Microbiol 1998;36(4):1164.
10. Chang KC, Su IJ, Tsai ST, Shieh DB, Jin YT. Pathological features of betel quid-related oral epithelial lesions in taiwan with special emphasis on the tumor progression and human papillomavirus association. Oncology 2002;63(4):362-9.
11. Neves D, Camara GNL, Alencar TR, Da Cruz MR, Martins CRF, Carvalho LGS. Prevalence of human papillomavirus in penile carcinoma. Braz J Urol 2002;28(3):221-6.
12. Hwang T. Detection and typing of human papillomavirus DNA by PCR using consensus primers in various cervical lesions of Korean women. J Korean Med Sci 1999;14(6):593-9.
13. Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, Vollmer N, et al. Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Microbiol 2004;42(7):3176-84.
14. Gheit T, Landi S, Gemignani F, Snijders PJ, Vaccarella S, Franceschi S, et al. Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J Clin Microbiol 2006;44(6):2025-31.
15. Yarki{dotless}n F. [Virology and epidemiology of human papillomavirus infections]. Klinik Aktuel Ti{dotless}p 2007;12(8):1-6.
16. de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007;7(7):453-9.
17. De Vuyst H, Clifford G, Li N, Franceschi S. HPV infection in Europe. Eur J Cancer 2009;45(15):2632-9.
18. Rota S, Biri A, Bozdayi G, Dinc B, Guner H. [Screening and genotyping of human papillomavirus by PCR from cervical biopsies and smears in different patient groups]. Journal of the Turkish Microbiological Society 2004;34(3):185-9.
19. Inal MM, Kose S, Yildirim Y, Ozdemir Y, Toz E, Ertopcu K, et al. The relationship between human papillomavirus infection and cervical intraepithelial neoplasia in Turkish women. Int J Gynecol Cancer 2007;17(6):1266-70.
20. Ozturk S, Kaleli I, Kaleli B, Bir F. [Investigation of human papillomavirus DNA in cervical specimens by hybrid capture assay]. Mikrobiyol Bul 2004;38(3):223-32.
21. Dursun P, Senger SS, Arslan H, Kuşcu E, Ayhan A. Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit. BMC Infect Dis 2009;9:191.
22. Cuschieri KS, Cubie HA, Whitley MW, Seagar AL, Arends MJ, Moore C, et al. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 2004;57(1):68-72.
23. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection among females in the United States. JAMA 2007;297(8):813-9.
24. Thomas JO, Herrero R, Omigbodun AA, Ojemakinde K, Ajayi IO, Fawole A, et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 2004;90(3):638-45.
25. Dai M, Bao YP, Li N, Clifford GM, Vaccarella S, Snijders PJ, et al. Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer 2006;95(1):96-101.
26. Shin HR, Lee DH, Herrero R, Smith JS, Vaccarella S, Hong SH, et al. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer 2003;103(3):413-21.
27. Sanchez-Anguiano LF, Alvarado-Esquivel C, Reyes-Romero MA, Carrera-Rodriguez M. Human papillomavirus infections in women seeking cervical Papanicolaou cytology of Durango, Mexico: prevalence and genotypes. BMC Infect Dis 2006;6:27.
28. de Sanjose S, Almirall R, Lloveras B, Font R, Diaz M, Munoz N, et al. Cervical human papillomavirus infection in the female population in Barcelona, Spain. Sex Transm Dis 2003;30(10):788-93.
29. Verteramo R, Pierangeli A, Calzolari E, Patella A, Recine N, Mancini E, et al. Direct sequencing of HPV DNA detected in gynaecologic outpatients in Rome, Italy. Microbes Infect 2006;8(9-10):2517-21.
30. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D; 2006 ASCCP-Sponsored Consensus Conference. 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis 2007;11(4):201-22.
31. Gunnell AS, Tran TN, Torrang A, Dickman PW, Sparen P, Palmgren J, et al. Synergy between cigarette smoking and human papillomavirus type 16 in cervical cancer in situ development. Cancer Epidemiol Biomarkers Prev 2006;15(11):2141-7.
32. Giuliano AR, Sedjo RL, Roe DJ, Harri R, Baldwi S, Papenfuss MR, et al. Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States). Cancer Causes Control 2002;13(9):839-46.
33. Davidson M, Schnitzer PG, Bulkow LR, Parkinson AJ, Schloss ML, Fitzgerald MA, et al. The prevalence of cervical infection with human papillomaviruses and cervical dysplasia in Alaska Native women. J Infect Dis 1994;169(4):792-800.
34. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55(2):74-108.